Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0134 | 0.1423 | 0.2582 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0134 | 0.1423 | 0.2582 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0134 | 0.1423 | 0.3189 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0114 | 0.1142 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.1142 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Giardia lamblia | Kinase, PLK | 0.0114 | 0.1142 | 0.5 |
Schistosoma mansoni | apoptosis regulator bax | 0.0134 | 0.1423 | 0.2582 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0354 | 0.4462 | 0.3748 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0354 | 0.4462 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.1423 | 0.3189 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0134 | 0.1423 | 0.3189 |
Mycobacterium ulcerans | isocitrate lyase AceAb | 0.0558 | 0.7288 | 0.5 |
Mycobacterium leprae | PROBABLE ISOCITRATE LYASE AceA (ISOCITRASE) (ISOCITRATASE) (ICL) | 0.0558 | 0.7288 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0134 | 0.1423 | 0.2582 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.1142 | 0.256 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) | 0.0558 | 0.7288 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.1142 | 0.1897 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.1142 | 1 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0754 | 1 | 1 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) | 0.0558 | 0.7288 | 0.5 |
Trypanosoma brucei | polo-like protein kinase | 0.0114 | 0.1142 | 0.5 |
Mycobacterium ulcerans | isocitrate lyase Icl | 0.0558 | 0.7288 | 0.5 |
Mycobacterium tuberculosis | Isocitrate lyase Icl (isocitrase) (isocitratase) | 0.0558 | 0.7288 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.1142 | 0.5 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.1142 | 0.256 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0134 | 0.1423 | 0.2582 |
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0354 | 0.4462 | 1 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0134 | 0.1423 | 0.0317 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0354 | 0.4462 | 0.3748 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0134 | 0.1423 | 0.0317 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 0.1142 | 0.5 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.1142 | 0.5 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0354 | 0.4462 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CL (ADMET) | = 32 ml/min.kg | Clearance in iv dosed mouse | ChEMBL. | 20594842 |
IC50 (binding) | = 3 nM | Inhibition of PLK1 by SPA assay | ChEMBL. | 20594842 |
IC50 (functional) | = 30 nM | Cytotoxicity against human HCT116 cells after 72 hrs by celltiter-glo assay | ChEMBL. | 20594842 |
IC50 (ADMET) | = 0.2 uM | Inhibition of human recombinant CYP2C9 using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate by fluorescence plate reader | ChEMBL. | 20594842 |
IC50 (ADMET) | = 0.4 uM | Inhibition of human recombinant CYP3A4 using diethoxyfluorescein as substrate by fluorescence plate reader | ChEMBL. | 20594842 |
IC50 (ADMET) | = 1.9 uM | Inhibition of human recombinant CYP3A4 using 7-benzyloxyquinoline as substrate by fluorescence plate reader | ChEMBL. | 20594842 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 20594842 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.